Global Bacille Calmette-Gu?rin Vaccine Market Growth 2023-2029

February 2023 | 99 pages | ID: G402944945F9EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Bacille Calmette-Gu?rin Vaccine Industry Forecast” looks at past sales and reviews total world Bacille Calmette-Gu?rin Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacille Calmette-Gu?rin Vaccine sales for 2023 through 2029. With Bacille Calmette-Gu?rin Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacille Calmette-Gu?rin Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Bacille Calmette-Gu?rin Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacille Calmette-Gu?rin Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bacille Calmette-Gu?rin Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacille Calmette-Gu?rin Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacille Calmette-Gu?rin Vaccine.

The global Bacille Calmette-Gu?rin Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Bacille Calmette-Gu?rin Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Bacille Calmette-Gu?rin Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Bacille Calmette-Gu?rin Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Bacille Calmette-Gu?rin Vaccine players cover Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India and GSBPL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Bacille Calmette-Gu?rin Vaccine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Immune Bacille Calmette-Gu?rin
• Therapy Bacille Calmette-Gu?rin

Segmentation by application

• Infants Under 3 Months
• Children Test Negative With 5IUPPD

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Sanofi Pasteur
• Japan BCG Lab
• China National Biotec
• Serum Institute of India
• GSBPL

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bacille Calmette-Gu?rin Vaccine market?

What factors are driving Bacille Calmette-Gu?rin Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bacille Calmette-Gu?rin Vaccine market opportunities vary by end market size?

How does Bacille Calmette-Gu?rin Vaccine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bacille Calmette-Gu?rin Vaccine Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Bacille Calmette-Gu?rin Vaccine by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Bacille Calmette-Gu?rin Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Bacille Calmette-Gu?rin Vaccine Segment by Type
  2.2.1 Immune Bacille Calmette-Gu?rin
  2.2.2 Therapy Bacille Calmette-Gu?rin
2.3 Bacille Calmette-Gu?rin Vaccine Sales by Type
  2.3.1 Global Bacille Calmette-Gu?rin Vaccine Sales Market Share by Type (2018-2023)
  2.3.2 Global Bacille Calmette-Gu?rin Vaccine Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Bacille Calmette-Gu?rin Vaccine Sale Price by Type (2018-2023)
2.4 Bacille Calmette-Gu?rin Vaccine Segment by Application
  2.4.1 Infants Under 3 Months
  2.4.2 Children Test Negative With 5IUPPD
2.5 Bacille Calmette-Gu?rin Vaccine Sales by Application
  2.5.1 Global Bacille Calmette-Gu?rin Vaccine Sale Market Share by Application (2018-2023)
  2.5.2 Global Bacille Calmette-Gu?rin Vaccine Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Bacille Calmette-Gu?rin Vaccine Sale Price by Application (2018-2023)

3 GLOBAL BACILLE CALMETTE-GU?RIN VACCINE BY COMPANY

3.1 Global Bacille Calmette-Gu?rin Vaccine Breakdown Data by Company
  3.1.1 Global Bacille Calmette-Gu?rin Vaccine Annual Sales by Company (2018-2023)
  3.1.2 Global Bacille Calmette-Gu?rin Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Bacille Calmette-Gu?rin Vaccine Annual Revenue by Company (2018-2023)
  3.2.1 Global Bacille Calmette-Gu?rin Vaccine Revenue by Company (2018-2023)
  3.2.2 Global Bacille Calmette-Gu?rin Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Bacille Calmette-Gu?rin Vaccine Sale Price by Company
3.4 Key Manufacturers Bacille Calmette-Gu?rin Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bacille Calmette-Gu?rin Vaccine Product Location Distribution
  3.4.2 Players Bacille Calmette-Gu?rin Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BACILLE CALMETTE-GU?RIN VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Bacille Calmette-Gu?rin Vaccine Market Size by Geographic Region (2018-2023)
  4.1.1 Global Bacille Calmette-Gu?rin Vaccine Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Bacille Calmette-Gu?rin Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bacille Calmette-Gu?rin Vaccine Market Size by Country/Region (2018-2023)
  4.2.1 Global Bacille Calmette-Gu?rin Vaccine Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Bacille Calmette-Gu?rin Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bacille Calmette-Gu?rin Vaccine Sales Growth
4.4 APAC Bacille Calmette-Gu?rin Vaccine Sales Growth
4.5 Europe Bacille Calmette-Gu?rin Vaccine Sales Growth
4.6 Middle East & Africa Bacille Calmette-Gu?rin Vaccine Sales Growth

5 AMERICAS

5.1 Americas Bacille Calmette-Gu?rin Vaccine Sales by Country
  5.1.1 Americas Bacille Calmette-Gu?rin Vaccine Sales by Country (2018-2023)
  5.1.2 Americas Bacille Calmette-Gu?rin Vaccine Revenue by Country (2018-2023)
5.2 Americas Bacille Calmette-Gu?rin Vaccine Sales by Type
5.3 Americas Bacille Calmette-Gu?rin Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bacille Calmette-Gu?rin Vaccine Sales by Region
  6.1.1 APAC Bacille Calmette-Gu?rin Vaccine Sales by Region (2018-2023)
  6.1.2 APAC Bacille Calmette-Gu?rin Vaccine Revenue by Region (2018-2023)
6.2 APAC Bacille Calmette-Gu?rin Vaccine Sales by Type
6.3 APAC Bacille Calmette-Gu?rin Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bacille Calmette-Gu?rin Vaccine by Country
  7.1.1 Europe Bacille Calmette-Gu?rin Vaccine Sales by Country (2018-2023)
  7.1.2 Europe Bacille Calmette-Gu?rin Vaccine Revenue by Country (2018-2023)
7.2 Europe Bacille Calmette-Gu?rin Vaccine Sales by Type
7.3 Europe Bacille Calmette-Gu?rin Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bacille Calmette-Gu?rin Vaccine by Country
  8.1.1 Middle East & Africa Bacille Calmette-Gu?rin Vaccine Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Bacille Calmette-Gu?rin Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Bacille Calmette-Gu?rin Vaccine Sales by Type
8.3 Middle East & Africa Bacille Calmette-Gu?rin Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacille Calmette-Gu?rin Vaccine
10.3 Manufacturing Process Analysis of Bacille Calmette-Gu?rin Vaccine
10.4 Industry Chain Structure of Bacille Calmette-Gu?rin Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bacille Calmette-Gu?rin Vaccine Distributors
11.3 Bacille Calmette-Gu?rin Vaccine Customer

12 WORLD FORECAST REVIEW FOR BACILLE CALMETTE-GU?RIN VACCINE BY GEOGRAPHIC REGION

12.1 Global Bacille Calmette-Gu?rin Vaccine Market Size Forecast by Region
  12.1.1 Global Bacille Calmette-Gu?rin Vaccine Forecast by Region (2024-2029)
  12.1.2 Global Bacille Calmette-Gu?rin Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bacille Calmette-Gu?rin Vaccine Forecast by Type
12.7 Global Bacille Calmette-Gu?rin Vaccine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Bacille Calmette-Gu?rin Vaccine Product Portfolios and Specifications
  13.1.3 Merck Bacille Calmette-Gu?rin Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
  13.2.1 Sanofi Pasteur Company Information
  13.2.2 Sanofi Pasteur Bacille Calmette-Gu?rin Vaccine Product Portfolios and Specifications
  13.2.3 Sanofi Pasteur Bacille Calmette-Gu?rin Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Sanofi Pasteur Main Business Overview
  13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
  13.3.1 Japan BCG Lab Company Information
  13.3.2 Japan BCG Lab Bacille Calmette-Gu?rin Vaccine Product Portfolios and Specifications
  13.3.3 Japan BCG Lab Bacille Calmette-Gu?rin Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Japan BCG Lab Main Business Overview
  13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
  13.4.1 China National Biotec Company Information
  13.4.2 China National Biotec Bacille Calmette-Gu?rin Vaccine Product Portfolios and Specifications
  13.4.3 China National Biotec Bacille Calmette-Gu?rin Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 China National Biotec Main Business Overview
  13.4.5 China National Biotec Latest Developments
13.5 Serum Institute of India
  13.5.1 Serum Institute of India Company Information
  13.5.2 Serum Institute of India Bacille Calmette-Gu?rin Vaccine Product Portfolios and Specifications
  13.5.3 Serum Institute of India Bacille Calmette-Gu?rin Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Serum Institute of India Main Business Overview
  13.5.5 Serum Institute of India Latest Developments
13.6 GSBPL
  13.6.1 GSBPL Company Information
  13.6.2 GSBPL Bacille Calmette-Gu?rin Vaccine Product Portfolios and Specifications
  13.6.3 GSBPL Bacille Calmette-Gu?rin Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 GSBPL Main Business Overview
  13.6.5 GSBPL Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bacille Calmette-Guerin Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bacille Calmette-Guerin Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Immune Bacille Calmette-Guerin
Table 4. Major Players of Therapy Bacille Calmette-Guerin
Table 5. Global Bacille Calmette-Guerin Vaccine Sales by Type (2018-2023) & (Units)
Table 6. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Bacille Calmette-Guerin Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Bacille Calmette-Guerin Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Bacille Calmette-Guerin Vaccine Sales by Application (2018-2023) & (Units)
Table 11. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Bacille Calmette-Guerin Vaccine Revenue by Application (2018-2023)
Table 13. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Bacille Calmette-Guerin Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Bacille Calmette-Guerin Vaccine Sales by Company (2018-2023) & (Units)
Table 16. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Bacille Calmette-Guerin Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Bacille Calmette-Guerin Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Bacille Calmette-Guerin Vaccine Producing Area Distribution and Sales Area
Table 21. Players Bacille Calmette-Guerin Vaccine Products Offered
Table 22. Bacille Calmette-Guerin Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bacille Calmette-Guerin Vaccine Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Bacille Calmette-Guerin Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bacille Calmette-Guerin Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bacille Calmette-Guerin Vaccine Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bacille Calmette-Guerin Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bacille Calmette-Guerin Vaccine Sales by Country (2018-2023) & (Units)
Table 34. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Bacille Calmette-Guerin Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Bacille Calmette-Guerin Vaccine Sales by Type (2018-2023) & (Units)
Table 38. Americas Bacille Calmette-Guerin Vaccine Sales by Application (2018-2023) & (Units)
Table 39. APAC Bacille Calmette-Guerin Vaccine Sales by Region (2018-2023) & (Units)
Table 40. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Bacille Calmette-Guerin Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Bacille Calmette-Guerin Vaccine Sales by Type (2018-2023) & (Units)
Table 44. APAC Bacille Calmette-Guerin Vaccine Sales by Application (2018-2023) & (Units)
Table 45. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2018-2023) & (Units)
Table 46. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2018-2023) & (Units)
Table 50. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Bacille Calmette-Guerin Vaccine
Table 58. Key Market Challenges & Risks of Bacille Calmette-Guerin Vaccine
Table 59. Key Industry Trends of Bacille Calmette-Guerin Vaccine
Table 60. Bacille Calmette-Guerin Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bacille Calmette-Guerin Vaccine Distributors List
Table 63. Bacille Calmette-Guerin Vaccine Customer List
Table 64. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bacille Calmette-Guerin Vaccine Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Bacille Calmette-Guerin Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Bacille Calmette-Guerin Vaccine Product Portfolios and Specifications
Table 80. Merck Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Sanofi Pasteur Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Portfolios and Specifications
Table 85. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi Pasteur Main Business
Table 87. Sanofi Pasteur Latest Developments
Table 88. Japan BCG Lab Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolios and Specifications
Table 90. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Japan BCG Lab Main Business
Table 92. Japan BCG Lab Latest Developments
Table 93. China National Biotec Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolios and Specifications
Table 95. China National Biotec Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. China National Biotec Main Business
Table 97. China National Biotec Latest Developments
Table 98. Serum Institute of India Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolios and Specifications
Table 100. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments
Table 103. GSBPL Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. GSBPL Bacille Calmette-Guerin Vaccine Product Portfolios and Specifications
Table 105. GSBPL Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GSBPL Main Business
Table 107. GSBPL Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Bacille Calmette-Guerin Vaccine
Figure 2. Bacille Calmette-Guerin Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bacille Calmette-Guerin Vaccine Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Bacille Calmette-Guerin Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bacille Calmette-Guerin Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Immune Bacille Calmette-Guerin
Figure 10. Product Picture of Therapy Bacille Calmette-Guerin
Figure 11. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type in 2022
Figure 12. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Bacille Calmette-Guerin Vaccine Consumed in Infants Under 3 Months
Figure 14. Global Bacille Calmette-Guerin Vaccine Market: Infants Under 3 Months (2018-2023) & (Units)
Figure 15. Bacille Calmette-Guerin Vaccine Consumed in Children Test Negative With 5IUPPD
Figure 16. Global Bacille Calmette-Guerin Vaccine Market: Children Test Negative With 5IUPPD (2018-2023) & (Units)
Figure 17. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2022)
Figure 18. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application in 2022
Figure 19. Bacille Calmette-Guerin Vaccine Sales Market by Company in 2022 (Units)
Figure 20. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Company in 2022
Figure 21. Bacille Calmette-Guerin Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Bacille Calmette-Guerin Vaccine Sales 2018-2023 (Units)
Figure 26. Americas Bacille Calmette-Guerin Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Bacille Calmette-Guerin Vaccine Sales 2018-2023 (Units)
Figure 28. APAC Bacille Calmette-Guerin Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Bacille Calmette-Guerin Vaccine Sales 2018-2023 (Units)
Figure 30. Europe Bacille Calmette-Guerin Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales 2018-2023 (Units)
Figure 32. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Bacille Calmette-Guerin Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Bacille Calmette-Guerin Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Bacille Calmette-Guerin Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Bacille Calmette-Guerin Vaccine
Figure 72. Industry Chain Structure of Bacille Calmette-Guerin Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Bacille Calmette-Guerin Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Application (2024-2029)